952138-09-9

Basic information

• Product Name: tert-butyl 2-[2-methoxy-4-(1,6-naphthyridin-4-yloxy)phenyl]acetate
• Synonyms: tert-butyl 2-[2-methoxy-4-(1,6-naphthyridin-4-yloxy)phenyl]acetate
• CAS NO: 952138-09-9
• Molecular Weight: 366.417
• Mol File: 952138-09-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: tert-butyl 2-[2-methoxy-4-(1,6-naphthyridin-4-yloxy)phenyl]acetate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 2-[2-methoxy-4-(1,6-naphthyridin-4-yloxy)phenyl]acetate(952138-09-9)
• EPA Substance Registry System: tert-butyl 2-[2-methoxy-4-(1,6-naphthyridin-4-yloxy)phenyl]acetate(952138-09-9)

Safety Data

• Hazardous Substances Data: 952138-09-9(Hazardous Substances Data)

Upstream product

• 948571-52-6 tert-butyl 2-(4-hydroxy-2-methoxyphenyl)acetate 
• 6861-84-3 4-chloro-[1,6]naphthyridine 
• 883985-70-4 2-(4-benzyloxy-2-methoxyphenyl)acetonitrile 
• 948571-54-8 tert-butyl [4-(benzyloxy)-2-methoxyphenyl]acetate 
• 58026-14-5 4-(benzyloxy)-2-methoxybenzaldehyde 
• 18278-34-7 4-hydroxy-2-methoxybenzaldehyde 
• 863310-59-2 [4-(benzyloxy)-2-methoxyphenyl]acetic acid 

Downstream Products

• 952138-08-8 2-[2-methoxy-4-(1,6-naphthyridin-4-yloxy)phenyl]acetic acid 

Relevant articles and documents

NAPHTHYRIDINE DERIVATIVES AS ANTI-CANCER AGENTS

The invention concerns naphthyridine derivatives of Formula (I): or a pharmaceutically-acceptable salt thereof, wherein each of X1, p, R1, G1, G2, q, R2, R3, R4, R5, Ring A, r and R6 has any of the meanings defined hereinbefore in the description; pharmaceutical compositions containing them and their use in the treatment of cell proliferative disorders or disease states associated with angiogenesis and/or vascular permeability.